Healthtech Startups

Aclaris develops investigational monoclonal antibodies and small-molecule inhibitors targeting immune pathways for the treatment of atopic, autoimmune, and respiratory diseases. The company's clinical and preclinical pipeline includes candidates in development for severe asthma, atopic dermatitis, and T-cell-mediated autoimmune conditions.

6 investors

Adaptimmune Therapeutics is a biotechnology company, though the specific focus of their therapeutic work is not detailed on this investors and media page.

6 investors

ADARx is a clinical-stage biotechnology company developing RNA-targeted therapeutics designed to control the expression of disease-driving genes. It focuses on treatments for a range of diseases with unmet medical needs.

6 investors

Adentris builds AI agents that automate healthcare revenue cycle management, specifically addressing unpaid claims and billing denials for mid-market healthcare providers. The platform reads patient charts and claims in real time to recover revenue that leaks through the billing process.

6 investors

AdvanCell is a clinical-stage radiopharmaceutical company developing a pipeline of targeted alpha therapies for the treatment of cancers including prostate, melanoma, ovarian, breast, and lung. Its lead-212-based programs, such as ADVC001 for metastatic prostate cancer, are in clinical development.

6 investors

Aether Biomedical develops bionic hands and rehabilitation devices for upper limb amputees using bio-signal processing technology. The company aims to make advanced prosthetics accessible and affordable globally.

6 investors

After provides affordable and transparent end-of-life planning and funeral services for families, shifting control from funeral homes to consumers with customizable options.

6 investors

Agomab is a clinical-stage biopharmaceutical company developing disease-modifying therapies for fibro-inflammatory and fibrotic diseases with high unmet medical need. Its product candidates target established biological pathways using organ-restricted approaches to resolve fibro-inflammation and restore organ function.

6 investors

Aidaly professionalizes family caregiving by connecting and supporting family caregivers to recognize their economic contribution. The company aims to formalize and value unpaid care work that traditionally goes unrecognized in economic metrics.

6 investors

Aide is a digital health app that helps patients self-manage multiple chronic conditions between clinic visits, improving medication adherence at scale. It supports patients with conditions such as asthma through record-keeping and medication reminders, with references to the NHS England healthcare context.

6 investors

AIQ Solutions develops intellectual property and technologies to improve clinical treatment outcomes for patients with complex diseases globally. The company combines scientific innovation with clinical validation to support clinician decision-making.

6 investors

AKASA provides generative AI solutions for healthcare revenue cycle management, helping health systems automate administrative workflows and reduce costs. The company builds AI assistants and workflow automation tools designed for revenue cycle teams at providers, payers, and healthcare organizations.

6 investors

Akouos is a precision genetic medicine company developing therapies for the inner ear to restore, improve, and preserve hearing. It focuses on treating the underlying causes of hearing loss, including genetic hearing loss.

6 investors

Alector develops therapies targeting neurodegenerative diseases including Alzheimer's, frontotemporal dementia, and Parkinson's disease through protein removal, replacement, and immune cell restoration. The company focuses on patients with neurodegenerative conditions and applies genetics, neuroscience, and immunology to advance new treatments.

6 investors

Alerje develops FAIT, a mobile app and clinical platform for food allergy oral immunotherapy (OIT), offering dose tracking, HIPAA-compliant clinic messaging, and predictive insights. It serves families managing childhood food allergies and the allergy clinics coordinating their care.

6 investors

Alimetry develops the Gastric Alimetry system, a non-invasive body surface gastric mapping device that provides objective diagnostics for patients with chronic gastrointestinal symptoms. It is used by hospitals and GI clinicians, with availability in New Zealand, Australia, the UK, and the US.

6 investors

Allotrope Medical makes electrical stimulation devices that integrate with surgical instruments to help surgeons visualize and assess urinary and digestive system structures during procedures. The technology targets surgeons performing abdominal and pelvic operations.

6 investors

Alvee is a software platform that identifies social and health barriers from clinical notes, automates patient outreach and follow-up, and generates compliant billing documentation for care coordination and navigation services in healthcare settings. It helps health systems and FQHCs capture reimbursable revenue from Medicare and Medicaid codes for care coordination, navigation, and social needs interventions.

6 investors

Alveus Therapeutics develops next-generation metabolic and obesity therapies, including its lead asset ALV-100 (in Phase 2) and a preclinical amylin pipeline of peptides, oral small molecules, and novel formats aimed at sustainable weight loss with better tolerability. The company uses human genetic data and clinical expertise to select drug targets in the obesity treatment landscape.

6 investors

ALX Oncology develops therapies for cancer treatment, operating in the biotechnology and medical technology sectors.

6 investors

AMBOSS is a digital medical knowledge platform serving doctors, medical students, and healthcare professionals worldwide with study materials, clinical reference content, and exam preparation tools. The platform serves over one million users across more than 180 countries and has been adopted by major medical schools and hospital networks.

6 investors

AMOpportunities operates a clinical training platform that connects medical, MBBS, and nursing students with clinical placements at U.S. and international healthcare sites, offering visa and immigration support. It also serves schools, hospitals, and preceptors with clinical placement management, administrative support, and accreditation compliance tools.

6 investors

AmorSui manufactures reusable personal protective equipment (PPE) designed to be more durable, sustainable, and inclusive than traditional disposable options. The company serves healthcare workers and other occupational safety professionals with machine-washable PPE that incorporates circular economy principles and inclusive sizing.

6 investors

Ancilia is a biotech company using CRISPR to create beneficial bacterial products, such as live biotherapeutics, that carry immunity against the viruses that destroy them. It develops computational and biological platforms to identify, characterize, and counter viruses within the microbiome (the virome).

6 investors